Table 1.
Sponsor | Type of DNA vaccine | Phase |
---|---|---|
HIV | ||
NIH Vaccine Research Center | Naked plasmid | 1 ongoinga |
Emory University | Prime-boost | 1 ongoing |
Epimmune | Naked plasmid | 1 ongoing |
Wyeth-Lederle | Naked plasmid | 1 completeda |
Wyeth-Lederle | Naked plasmid | 1 ongoing |
UMMS | Prime-boost | 1 ongoing |
Chiron | Prime-boost | 1 ongoing |
University of New South Wales | Prime-boost | 1 & 2 |
Cancer | ||
ImClone Systems/ | Naked plasmid | 1 ongoing |
Memorial Sloan-Kettering Cancer Center | ||
CTL ImmunoTherapies | Naked plasmid | 1 completed |
CTL ImmunoTherapies | Naked plasmid | 1 & 2 |
National Cancer Institute | Naked plasmid | 2 completed |
M.D. Anderson Cancer Center | Naked plasmid | 1 & 2 |
Corixa | Prime-boost | 1 ongoing |
Vical | Naked plasmid | 2 completed |
Ebola | ||
NIH Vaccine Research Center | Naked plasmid | 1 ongoing |
aTwo trials. Source: http://clinicaltrials.gov/